PHARMAC - Latest News [Page 1]

Major PHARMAC funding package agreed with Roche

Monday, 5 December 2016, 11:22 am | PHARMAC

PHARMAC has announced a major funding package with Roche for nine medicines covering ten different conditions. The package includes the funding of three new treatments and widening of access to three existing medicines for seven new indications, as ... More >>

Partnership to enhance responsible use of medicines

Friday, 28 October 2016, 1:32 pm | PHARMAC

PHARMAC is pleased to announce a new partnership to support prescribing decisions and promote the responsible use of medicines, says PHARMAC Deputy Medical Director, Dr Bryan Betty. More >>

Leadership changes for PHARMAC consumer advisory committee

Thursday, 4 August 2016, 11:19 am | PHARMAC

The Consumer Advisory Committee (CAC) is made up of members of the community who provide input to PHARMAC from a consumer or patient perspective. More >>

PHARMAC announces the funding of pembrolizumab

Tuesday, 2 August 2016, 2:13 pm | PHARMAC

PHARMAC is pleased to announce the funding of pembrolizumab, following successful commercial negotiations and evolution in evidence, says PHARMAC Director of Operations, Sarah Fitt. More >>

Over 100,000 people set to benefit from vaccines decisions

Thursday, 28 July 2016, 11:44 am | PHARMAC

PHARMAC has today announced changes to funded vaccines, which will benefit an extra 100,000 people, says PHARMAC Director of Operations Sarah Fitt. More >>

New Zealand public help improve PHARMAC decision making

Wednesday, 6 July 2016, 10:30 am | PHARMAC

6 July 2016 New Zealand public help improve PHARMAC decision making After listening to what New Zealanders had to say, PHARMAC has changed the way it makes decisions - the most significant change to its decision making in its 23 year history. “This ... More >>

PHARMAC devices savings to help hospitals manage budgets

Tuesday, 5 July 2016, 11:05 am | PHARMAC

New data from PHARMAC is predicting DHB hospital spending on surgical and medical devices will fall by about $25 million over coming years. And this is set to grow with a consultation released today that, if implemented, would save a further $3.2 ... More >>

Health sector feedback helps make the most of funding boost

Thursday, 9 June 2016, 2:25 pm | PHARMAC

PHARMAC is today announcing funding of six new treatments across important areas of health, including major advancements in the treatment of hepatitis C. More >>

PHARMAC seeking new Māori members for consumer committee

Tuesday, 23 February 2016, 10:40 am | PHARMAC

PHARMAC is seeking nominations for two Māori members of its Consumer Advisory Committee (CAC). More >>

New treatment options for patients with multiple sclerosis

Wednesday, 9 December 2015, 2:19 pm | PHARMAC

Funding for two new medicines will provide patients with more convenient options for treating multiple sclerosis. More >>

NZers getting access to best cancer medicines

Tuesday, 3 November 2015, 4:12 pm | PHARMAC

A new analysis of cancer medicine access in Australia and New Zealand shows that New Zealanders are getting access to the best cancer medicines available, says PHARMAC medical director Dr John Wyeth. More >>

Pharmac welcomes appointments to clinical committee

Friday, 17 July 2015, 10:31 am | PHARMAC

Pharmac welcomes appointments to clinical committee Pharmac medical director Dr John Wyeth is welcoming the appointment of a new Chair and two new members to the Pharmacology and Therapeutics Advisory Committee (PTAC). PTAC is a statutory committee ... More >>

New leadership, new members for PHARMAC consumer committee

Thursday, 9 July 2015, 10:17 am | PHARMAC

New leadership, new members for PHARMAC consumer committee Wellington smoking cessation advocate Shane Bradbrook has been appointed chair of PHARMAC’s Consumer Advisory Committee. Shane Bradbrook, a member of the Committee since 2010, will succeed Kate ... More >>

Moves to protect availability of haemophilia treatments

Monday, 6 July 2015, 3:45 pm | PHARMAC

In changes to take effect from 1 September, PHARMAC is moving to have a preferred brand of recombinant Factor VIII, while also maintaining full funding for the other three currently-funded haemophilia products. More >>

PHARMAC Moving to Next Stage of Medical Devices Activity

Tuesday, 14 April 2015, 11:17 am | PHARMAC

PHARMAC is now consulting on moving to the next stage in its hospital medical devices work – market share procurement. This next stage of activity would see PHARMAC offering suppliers an assured portion of the market in return for competitive pricing ... More >>

PHARMAC tender savings top $600 million

Tuesday, 17 March 2015, 11:41 am | PHARMAC

Estimated savings achieved through PHARMAC’s tender of off-patent medicines have now topped $600 million. PHARMAC has run a tender for off-patent medicines since 1997. The tender promotes competition among pharmaceutical companies to bid for sole ... More >>

PHARMAC in negotiations over rare disorders medicines

Friday, 27 February 2015, 9:03 am | PHARMAC

PHARMAC is in active negotiations with several suppliers as a result of its competitive process for rare disorders medicines. On the eve of World Rare Diseases Day, PHARMAC has announced that 28 proposals from eight suppliers emerged from its request for ... More >>

PHARMAC secures significant savings for DHBs

Thursday, 4 December 2014, 2:57 pm | PHARMAC

A new agreement for a high cost biologic drug will yield considerable savings for DHBs over the next five years, says PHARMAC. Infliximab is a monoclonal antibody, one of the so-called `targeted drugs’ used to treat auto-immune conditions like ... More >>

PHARMAC expands into new medical device category

Monday, 3 November 2014, 2:27 pm | PHARMAC

DHBs are expected to start making further savings in cardiac medical devices, after PHARMAC extended the range of products it already has under national contracts by beginning listing those used in cardiac procedures. More >>

PHARMAC approves largest single deal

Tuesday, 14 October 2014, 9:56 am | PHARMAC

Nearly 12,000 New Zealanders are set to benefit from major agreements that have been approved by PHARMAC. Agreements with two companies, Novartis and Biogen Idec, have been approved which will see 10 new medicines funded, and either reduced prices or ... More >>

 

 

InfoPages Links

 
 
 

LATEST HEADLINES

 
 
 
InfoPages
Search Scoop  
 
 
Powered by Vodafone
NZ independent news